What smart money is saying about Solventum Corporation
SOLV · Healthcare · Medical - Care Facilities · Market cap $11.21B
3 funds in our archive have pitched Solventum Corporation, most recently Diamond Hill Large Cap Fund in December 2025.
Company profile
Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The Medsurg segment is a provider of solutions including advanced wound care, I.V. site management, sterilization assurance, temperature management, surgical supplies, stethoscopes, and medical electrodes. The Dental Solutions segment provides a comprehensive suite of dental and orthodontic products including brackets, aligners, restorative cements, and bonding agents. The Health Information Systems provides software solutions including computer-assisted, physician documentation, direct-to-bill and coding automation, classification methodologies, speech, recognition, and data visualization platforms. The Purification and Filtration segment provides purification and filtration technologies including filters, purifiers, cartridges, and membranes. The company was incorporated in 2023 and is based in Saint Paul, Minnesota.
Get an email when a fund buys, sells or pitches it
11
Reported positions
2
Bought
0
Sold
14
Letters
Position history
Between Q4 2024 and Q3 2026, 11 fund letters reported a position in Solventum Corporation, with 2 buys (opened or added).
| Quarter | Letters | Bought | Sold | Theses |
|---|---|---|---|---|
| Q3 2026 | 3 | 0 | 0 | 0 |
| Q2 2026 | 2 | 0 | 0 | 0 |
| Q1 2026 | 2 | 0 | 0 | 0 |
| Q4 2025 | 1 | 0 | 0 | 1 |
| Q3 2025 | 1 | 1 | 0 | 1 |
| Q2 2025 | 1 | 0 | 0 | 0 |
| Q4 2024 | 1 | 1 | 0 | 1 |
Bought and Sold count moves: the same sentence published by several funds of one house in a quarter counts once.
Fund activity · 11 positions · 2 moves
- HoldsWS Ruffer Diversified Return FundSeptember 2026
“WS Ruffer Diversified Return Fund 30 Sep 26 5 LARGEST EQUITY HOLDINGS Stock % of fund Microsoft 0.9 Amazon 0.9 Solventum 0.8 Prudential 0.8 BP 0.7 ASSET ALLOCATION CURRENCY ALLOCATION Inflation % Long-dated non-UK inflation-linked bonds 16.8 Short-dated non-UK inflation-linked bonds 5.2 Gold and precious metals exposure 3.2 Protection Long-dated nominal bonds 21.5 Short-dated nominal bonds 13.9 Cash 1.7 Credit and derivative strategies 0.8 Growth Consumer discretionary equities 7.4 Energy equities 5.5 Financials equities 4.5 Industrials equities 4.1 Other equities 12.3 Commodity exposure 3.0 Currency allocation % Sterling 65.0 US dollar 15.9 Yen 11.0 Euro 4.7 Other 3.2 Geographical equity allocation North America equities 13.2 UK equities 8.8 Europe equities 5.9 Japan equities 4.0 Asia ex-Japan equities 1.8 FUND SIZE £1,446.4M FUND INFORMATION Annual management charge % 0.9 Minimum investment (or equivalent in other currency) £50m Ongoing Charges Figure % 0.93 Dealing frequency Daily Valuation point 12:00 Pay dates 15 May, 15 Nov Record dates 15 Mar, 15 Sep Investment manager Ruffer LLP Depositary The Bank of New York Mellon (International) Limited Authorised Corporate Director Waystone Management (UK) Limited Auditors Ernst & Young LLP Structure Sub-fund of WS Ruffer Managed Funds (OEIC) UK domiciled UCITS Eligible for ISAs Share class ISIN SEDOL I GBP acc GB00BMWLQW82 BMWLQW8 I GBP inc GB00BMWLQV75 BMWLQV7 The credit and derivatives strategies allocation is calculated using market value. In some cases, this allocation might be negative due to the nature of how the instruments, in particular credit default swaps, are priced. Largest equity holdings exclude Ruffer funds | Source: Ruffer LLP | Totals may not equal 100 due to rounding”
Solventum Corporation - September 2026
“6. Health Care has contributed positively to performance, primarily due to stock selection, with positive contributions from Thermo Fisher Scientific Inc. (TMO), Danaher Corporation (DHR), Waters Corporation (WAT), Becton, Dickinson and Company (BDX), and Solventum Corporation (SOLV), all more than offsetting negative performance from QIAGEN NV (QGEN).”
Solventum Corporation - HoldsWS Ruffer Diversified Return FundAugust 2026
“WS Ruffer Diversified Return Fund 31 Aug 26 5 LARGEST EQUITY HOLDINGS Stock % of fund BP 1.0 Microsoft 0.9 Amazon 0.9 Solventum 0.8 Prosus 0.8 ASSET ALLOCATION CURRENCY ALLOCATION Inflation % Long-dated non-UK inflation-linked bonds 14.0 Short-dated non-UK inflation-linked bonds 5.0 Gold and precious metals exposure 3.5 Protection Short-dated nominal bonds 20.2 Long-dated nominal bonds 17.4 Cash 2.2 Credit and derivative strategies 0.6 Growth Consumer discretionary equities 8.7 Energy equities 4.8 Industrials equities 4.4 Financials equities 4.4 Other equities 12.7 Commodity exposure 2.2 Currency allocation % Sterling 68.3 US dollar 12.6 Yen 10.1 Euro 5.0 Other 4.0 Geographical equity allocation North America equities 13.1 UK equities 8.5 Europe equities 6.8 Japan equities 3.7 Asia ex-Japan equities 2.9 FUND SIZE £1,479.1M FUND INFORMATION Annual management charge % 0.9 Minimum investment (or equivalent in other currency) £50m Ongoing Charges Figure % 0.93 Dealing frequency Daily Valuation point 12:00 Pay dates 15 May, 15 Nov Record dates 15 Mar, 15 Sep Investment manager Ruffer LLP Depositary The Bank of New York Mellon (International) Limited Authorised Corporate Director Waystone Management (UK) Limited Auditors Ernst & Young LLP Structure Sub-fund of WS Ruffer Managed Funds (OEIC) UK domiciled UCITS Eligible for ISAs Share class ISIN SEDOL I GBP acc GB00BMWLQW82 BMWLQW8 I GBP inc GB00BMWLQV75 BMWLQV7 The credit and derivatives strategies allocation is calculated using market value. In some cases, this allocation might be negative due to the nature of how the instruments, in particular credit default swaps, are priced. Largest equity holdings exclude Ruffer funds | Source: Ruffer LLP | Totals may not equal 100 due to rounding”
Solventum Corporation - HoldsMayar CapitalJune 2026
Listed in Mayar Capital’s reported holdings.
Solventum Corporation - June 2026
“3. Health Care was a relative headwind to performance, primarily due to stock selection, as our overweight positions in QIAGEN NV (QGEN), Solventum Corporation (SOLV), and Becton, Dickinson and Company (BDX) underperformed.”
Solventum Corporation - HoldsCambiar SMID FundMarch 2026
“Security selection within Healthcare comprised the largest drag on performance in the quarter, as Solventum and Phreesia each incurred sizable drawdowns. Solventum was spun off from 3M in 2024 and has three business segments: surgical equipment, dental solutions, and health IT systems. As a stand- alone company, Solventum is doing all the right things - positive organic growth across all units, deleveraging the balance sheet, and generating positive free cashflow. The recent price weakness is due to AI-related fears pressuring the company’s HCIT unit, which accounts for ~16% of sales. We remain constructive on the company and continue to maintain a position.”
Solventum Corporation - March 2026
“Solventum was spun off from 3M in 2024 and has three business segments: surgical equipment, dental solutions, and health IT systems. As a stand- alone company, Solventum is doing all the right things - positive organic growth across all units, deleveraging the balance sheet, and generating positive free cashflow. The recent price weakness is due to AI-related fears pressuring the company’s HCIT unit, which accounts for ~16% of sales. We remain constructive on the company and continue to maintain a position.”
Solventum Corporation - HoldsClipper FundDecember 2025
“Healthcare is an industry where there has been enormous volatility by sub-sector and by company, and the key again is to be opportunistic. We focus on companies we consider recession-resistant— those that have the characteristics of durability and strong sustainable demand. We like those parts of the industry that concentrate on services and generic pharmaceuticals and we avoid companies with big single drug exposures and similar risks. In this sector too we want to own businesses that can use AI to enhance earnings by reducing costs and improving the customer and patient experience. Our portfolio holdings include CVS Health, which has a very broad and resilient portfolio across healthcare services and products. We own Viatris, a maker of branded generics, not a glamorous business but a durable, reliable and steady source of cash flow. We also own Solventum, formed when 3M spun out its healthcare products business in 2024, and another example of durability in healthcare.”
Solventum Corporation - New positionPzena Focused ValueSeptember 2025
“We also initiated a new position in medical device company Solventum, a recent spinoff from 3M.”
Solventum Corporation - HoldsDavis Global FundJune 2025
“Solventum Solventum is a U.S. healthcare business spun out of 3M in April 2024. The company generated over $8 billion in revenue in 2024, most of which came from selling medical-surgical products (mostly for infection prevention and wound care) to hospitals and clinics. Solventum also sells products to dentist offices (e.g., consumables for preventive dental care) as well as coding and transcribing software to hospitals. The business has a long history of attractive growth and margins, but performance weakened under 3M ownership in recent years due to a lack of new product investment and poor integration of acquired businesses, among other factors. The management team, led by industry veteran Bryan Hanson, has deep healthcare experience and a successful collaboration under their belts at a prior healthcare spinoff (Covidien). They are highly focused on reinvigorating earnings growth (back to approximately 4–5% annually) and growing margins. They have also approached the portfolio with fresh eyes, which led to an agreement to sell a non-core purification and filtration business to Thermo Fisher Scientific for an attractive price. Key risks include leverage (which will improve once the company receives proceeds from the sale), as well as the operational risks from standing up independent systems and disentangling from former parent 3M. We bought most of our shares in the heavy selling that accompanied the spinoff post-separation at an attractive valuation of 10x owner earnings.”
Solventum Corporation - New positionDiamons Hill Small Mid Cap FundDecember 2024
“We initiated a number of new positions in Q4, including ICON, Informatica, Teleflex Incorporated, Teledyne Technologies, Rexford Industrial Realty and Solventum Corporation.”
Solventum Corporation
Fund coverage · 3 theses
- Diamond Hill Large Cap FundDecember 2025
Solventum is a medical products and health care IT company spun from 3M with potential for improved growth and margins under new management.
Read the full thesis - Mayar CapitalSeptember 2025
Solventum is a newly spun-off healthcare company from 3M, well-positioned for growth and innovation despite inheriting a challenging financial situation, and is focused on simplifying its portfolio and enhancing operational efficiency.
Read the full thesis - Diamond Hill Mid Cap FundDecember 2024
Solventum is a newly independent company focused on driving revenue growth and optimizing R&D to enhance its product offerings and address critical patient needs.
Read the full thesis
Read every full thesis on Solventum Corporation
Read all 3 theses in full, with each fund's reasoning, and get unlimited access to the archive.
View plans→Share this ledger